Diskussion zu Datametrex -- Covid19 Test Kits
eröffnet am 17.12.17 09:05:30 von
neuester Beitrag 27.03.23 09:28:45 von
neuester Beitrag 27.03.23 09:28:45 von
WKN: A2DYN5 · Symbol: DM
0,066
EUR
+5,25 %
+0,003 EUR
Letzter Kurs 13:57:50 · Tradegate
Werte aus der Branche Informationstechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,520 | +5.100,00 | |
| 5,400 | +424,27 | |
| 0,510 | +397,08 | |
| 0,600 | +46,31 | |
| 1,000 | +28,21 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,550 | -21,43 | |
| 0,615 | -21,54 | |
| 2,866 | -22,16 | |
| 27,00 | -22,86 | |
| 1,000 | -61,24 |
Beitrag zu dieser Diskussion schreiben
Feedback
Moin Euch allen, ja hier kann ich nur zustimmen. Die Börsensituation sieht jeder selbst. Es ist einfach keine Zeit für Bullen. Und wenn kein Kapital an die Börse getragen wird, dann geht hier halt auch nichts. Das sieht man an den extrem geringen Volumina die gehandelt werden. Ich meine was sind bitte schon 5.000 oder nen paar wenige 10.000 Aktien, wenn Datametrex rund 410.000.000 Aktien hat. Genau, das sind nicht mal 0,002 Prozent Handelsvolumen. Da kann ja nix gehen. Das hat aber auch den Vorteil, dass diejenigen die DM kennen und um deren Zahlen wissen und wissen, dass da schon bald ein fetter zweiter KI-"Meilenstein" kommt, zu diesen lächerlichen Kursen nachlegen können.
Ich bin leider blank und halte eben an meinen Aktien fest, bis die Zeit für die Bullen wieder gekommen ist. Dann freue ich mich umso mehr, dass ich das Tal der Bären durchschritten und Geduld und Vertrauen bewiesen habe
2024 wird besser.
Viele Grüße
Stefan
Ich bin leider blank und halte eben an meinen Aktien fest, bis die Zeit für die Bullen wieder gekommen ist. Dann freue ich mich umso mehr, dass ich das Tal der Bären durchschritten und Geduld und Vertrauen bewiesen habe
2024 wird besser.
Viele Grüße
Stefan
@Daxfurz moin nicht mehr wie vor einem halben Jahr ca. Da habe ich die Personal Situation schon mal angeschnitten. Bin nach wie vor der Meinung das wir die 0,20€ im Dezember sehen. Sollte es im August andere Ergebnisse oder keine gehen,wie jetzt angepeilt werde ich mein Invest überdenken. Was ich regelmäßig mit allen Invest mache. Weiter bin ich der Meinung das wir Glück hatten das sich diese AG ein Profil zugelegt hat. Die Firma ist agil und hat sich dadurch ein sehr ansehnliches Polster (finanziell) aufgebaut. Was wäre mit dem Kurs ohne corona passiert ??? Jeder der sich hier negativ äußert (nur weil der Kurs nicht bei 0,25€ steht)sollte sich mal hinterfragen warum er hier investiert hat. !!!! Kommt da etwas anderes raus als " schneller Zock " Reichtum über Nacht " dann ist es meine Meinung die mir sagt bleib dabei. Oder wie ich es immer gesagt habe. Geduld und Vertrauen
Antwort auf Beitrag Nr.: 73.547.422 von Chash-Carry am 24.03.23 14:23:48
Höre ich da etwa Zweifel zwischen den Zeilen? 😎
Es entwickelt sich langsam als gedacht und das Börsenumfeld sieht jeder selber.
Das es auch scheitern kann, hatte ich mal erwähnt.
Alles wird gut!🤪
Höre ich da etwa Zweifel zwischen den Zeilen? 😎
Es entwickelt sich langsam als gedacht und das Börsenumfeld sieht jeder selber.
Das es auch scheitern kann, hatte ich mal erwähnt.
Alles wird gut!🤪
Na das der TSX Börsenwechsel erst einmal hinten ansteht finde ich auch nicht so toll. Lässt sich aber ohne ALLE anderen Projekte zu vernachlässigen leider finanziell nicht umsetzten. Da fehlt dann einfach das chash . Frage mich sowieso wie die das mit der wenigen man- Frauen- Power bewerkstelligen
so viele Projekte vorwärts zu bringen. Die MediCall kann echt ertragreich werden habe die Zahlen von Well Health Tech gelesen. Echt sehr stark. Also wie gesagt ich gebe Datametrex AI erstmal bis August dann bewerte ich neu und hoffe das ich mit Geduld und Vertrauen gut gefahren bin.
so viele Projekte vorwärts zu bringen. Die MediCall kann echt ertragreich werden habe die Zahlen von Well Health Tech gelesen. Echt sehr stark. Also wie gesagt ich gebe Datametrex AI erstmal bis August dann bewerte ich neu und hoffe das ich mit Geduld und Vertrauen gut gefahren bin.
Antwort auf Beitrag Nr.: 73.542.316 von casbah95 am 23.03.23 23:18:16Ja, korrekt, die Hürde TSX derzeit wohl zu hoch, das Geld wird anderweitig wohl nötiger gebraucht. Die Sache mit der AnalyticsGPT wird etwas nach hinten gereicht, aber nach wie vor nicht zu verachten....man muss eben Geduld mitbringen und auf die nächsten Nachrichten warten....abwarten, aber verkaufen ist für mich derzeit kein Thema....
Trading Spotlight
Antwort auf Beitrag Nr.: 73.539.316 von Chash-Carry am 23.03.23 16:28:16Ich bin ehrlicherweise etwas enttäuscht über die Medi-Call Nutzerzahl und die 10 Mio. Hürde für die TSX... Wie bereits einige Vorredner angesprochen haben, scheint das Marketing bei DataMetrex vor einigen Hürden zu stehen.
Ich bleibe gespannt, ob ich bis 2025 1-2stellige €-Kurse sehe
Ich bleibe gespannt, ob ich bis 2025 1-2stellige €-Kurse sehe
Danke casbah95 gute Information. Dann warten wir auf August. 😀 und schauen mal was davon eingetreten ist.
Uplisting auf On hold und 281 Medi-Call App Subscriber...
https://www.datametrex.com/so/24OSBBDs-?languageTag=en&cid=e…
NEWS RELEASE
DATAMETREX CORPORATE UPDATE MARCH 2023
Toronto, Canada, March 23, 2023 – Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) is pleased to announce a corporate update on its latest developments and provide an outlook for future plans.
Nexalogy Environics Inc. (“Nexalogy”)
Nexalogy is currently dedicated to expanding the reach and user base of AnalyticsGPT. To achieve this, the company will be deploying targeted advertising and presenting its AI tool at various conferences to reach a wider range of businesses. The company has received substantial interest in its AI product from potential clients, which makes this rollout a critical point in the development process. To ensure smooth expansion, the Company is taking on a structured approach, similar to early access for video games. While scaling the system and working out any kinks, the user base will be expanded as aggressively as possible. In Q2, the company will focus on onboarding small and medium enterprises (SMEs) while simultaneously polishing AnalyticsGPT for the retail sector. To cater to retail clients, the Company plans to launch a subscription based-model of AnalyticsGPT in Q3.
Nexalogy Key Milestone:
Week ending March 25:
Wrapping up the first pass of the beta test for AnalyticsGPT
Week ending March 31:
Evaluating the results of the beta and inviting new companies to participate
Scaling AnalyticsGPT to meet demand
April / May:
Moving beta to early access for AnalyticsGPT with price points and converting some customers to paid plans
Working with existing partners to expand the reach of AnalyticsGPT in Korea
Continuing work on milestones for IDEaS Government Contract
Launching the new UIs and other pieces of AnalyticsGPT that are not cleared yet
June:
Launching several new business verticals inside AnalyticsGPT along with further Company expansion
July / August:
AnalyticsGPT full availability
Medi-Call Inc. (“Medi-Call”)
The Company has seen a healthy increase in Medi-Call’s performance since expanding from British Columbia to Ontario and Alberta. To date, Medi-Call reports 281 subscribers using its telehealth platform. The Company saw a 25% increase in new subscribers in Q1, 2023. Medi-Call has also been providing its telehealth services to clients in the film and production industry which will be reflected in the Company’s Q4 2022 revenue.
The Company has an aggressive strategy in place to elevate the Medi-Call platform to more successful heights. Medi-Call plans on leveraging the Company’s AI technology and integrating it into its telehealth platform to enhance user and patient experience. The Company’s advanced AI and GPT technology will be used to enhance the Medi-Call platform with AI features which will differentiate Medi-Call from its competitors and accelerate its platform.
The Company projects a further surge in its subscriber base as it starts to deploy advertising for all three provinces and is aiming for increased revenue in this sector by year-end.
Imagine Health Centres (“Imagine Health”)
The Company has established two (2) Imagine Health Centres in Calgary and Edmonton, and is currently in the process of opening a third clinic in Vancouver. Discussions are underway to open a fourth clinic in Ontario. Furthermore, the Company plans to enhance its offerings by adding a Wellness Center to its two (2) existing clinics, which will provide a range of services such as physiotherapy, IV Vitamin Therapy treatment, acupuncture, and more. These developments are expected to improve the Company's revenue once implemented.
Datametrex Electric Vehicle Solutions (“DMEVS”)
The DMEVS app is nearing completion, with final approval for iOS currently underway. The Company has experienced delays due to the integration of DMEVS technology, which originates from Korea, and therefore had to make necessary modifications to its technology to meet Canadian standards. Additionally, the payment system has been adapted to reflect Canadian standards.
Additionally, while some DMEVS charging stations are already available in Vancouver, expansion to further locations is pending permit approval from the City of Vancouver. Installation of these new stations will proceed as soon as permits are granted.
The Company is continuously pursuing exciting developments for DMEVS and anticipates announcing further updates as they come.
TSX Uplist
Lastly, the Company would like to provide an update on its journey towards uplisting on the main board. Despite the Company’s strong cash position with operating cash flow, the exchange has mandated a $10M broker financing prerequisite to uplist. Management is working diligently with the board to evaluate the situation and is exploring all available options to overcome this challenge. As a result, the Company’s uplisting plans are currently on hold due to this requirement, pending further developments.
“We have an exciting year ahead of us in 2023 with a range of plans and initiatives in the pipeline. We are proud to be at the forefront of some of the leading industries and we remain committed to driving continued value and growth for our stakeholders. We look forward to sharing more on our progress with our valued investors, customers, and partners” said Marshall Gunter, CEO of the Company.
https://www.datametrex.com/so/24OSBBDs-?languageTag=en&cid=e…
NEWS RELEASE
DATAMETREX CORPORATE UPDATE MARCH 2023
Toronto, Canada, March 23, 2023 – Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) is pleased to announce a corporate update on its latest developments and provide an outlook for future plans.
Nexalogy Environics Inc. (“Nexalogy”)
Nexalogy is currently dedicated to expanding the reach and user base of AnalyticsGPT. To achieve this, the company will be deploying targeted advertising and presenting its AI tool at various conferences to reach a wider range of businesses. The company has received substantial interest in its AI product from potential clients, which makes this rollout a critical point in the development process. To ensure smooth expansion, the Company is taking on a structured approach, similar to early access for video games. While scaling the system and working out any kinks, the user base will be expanded as aggressively as possible. In Q2, the company will focus on onboarding small and medium enterprises (SMEs) while simultaneously polishing AnalyticsGPT for the retail sector. To cater to retail clients, the Company plans to launch a subscription based-model of AnalyticsGPT in Q3.
Nexalogy Key Milestone:
Week ending March 25:
Wrapping up the first pass of the beta test for AnalyticsGPT
Week ending March 31:
Evaluating the results of the beta and inviting new companies to participate
Scaling AnalyticsGPT to meet demand
April / May:
Moving beta to early access for AnalyticsGPT with price points and converting some customers to paid plans
Working with existing partners to expand the reach of AnalyticsGPT in Korea
Continuing work on milestones for IDEaS Government Contract
Launching the new UIs and other pieces of AnalyticsGPT that are not cleared yet
June:
Launching several new business verticals inside AnalyticsGPT along with further Company expansion
July / August:
AnalyticsGPT full availability
Medi-Call Inc. (“Medi-Call”)
The Company has seen a healthy increase in Medi-Call’s performance since expanding from British Columbia to Ontario and Alberta. To date, Medi-Call reports 281 subscribers using its telehealth platform. The Company saw a 25% increase in new subscribers in Q1, 2023. Medi-Call has also been providing its telehealth services to clients in the film and production industry which will be reflected in the Company’s Q4 2022 revenue.
The Company has an aggressive strategy in place to elevate the Medi-Call platform to more successful heights. Medi-Call plans on leveraging the Company’s AI technology and integrating it into its telehealth platform to enhance user and patient experience. The Company’s advanced AI and GPT technology will be used to enhance the Medi-Call platform with AI features which will differentiate Medi-Call from its competitors and accelerate its platform.
The Company projects a further surge in its subscriber base as it starts to deploy advertising for all three provinces and is aiming for increased revenue in this sector by year-end.
Imagine Health Centres (“Imagine Health”)
The Company has established two (2) Imagine Health Centres in Calgary and Edmonton, and is currently in the process of opening a third clinic in Vancouver. Discussions are underway to open a fourth clinic in Ontario. Furthermore, the Company plans to enhance its offerings by adding a Wellness Center to its two (2) existing clinics, which will provide a range of services such as physiotherapy, IV Vitamin Therapy treatment, acupuncture, and more. These developments are expected to improve the Company's revenue once implemented.
Datametrex Electric Vehicle Solutions (“DMEVS”)
The DMEVS app is nearing completion, with final approval for iOS currently underway. The Company has experienced delays due to the integration of DMEVS technology, which originates from Korea, and therefore had to make necessary modifications to its technology to meet Canadian standards. Additionally, the payment system has been adapted to reflect Canadian standards.
Additionally, while some DMEVS charging stations are already available in Vancouver, expansion to further locations is pending permit approval from the City of Vancouver. Installation of these new stations will proceed as soon as permits are granted.
The Company is continuously pursuing exciting developments for DMEVS and anticipates announcing further updates as they come.
TSX Uplist
Lastly, the Company would like to provide an update on its journey towards uplisting on the main board. Despite the Company’s strong cash position with operating cash flow, the exchange has mandated a $10M broker financing prerequisite to uplist. Management is working diligently with the board to evaluate the situation and is exploring all available options to overcome this challenge. As a result, the Company’s uplisting plans are currently on hold due to this requirement, pending further developments.
“We have an exciting year ahead of us in 2023 with a range of plans and initiatives in the pipeline. We are proud to be at the forefront of some of the leading industries and we remain committed to driving continued value and growth for our stakeholders. We look forward to sharing more on our progress with our valued investors, customers, and partners” said Marshall Gunter, CEO of the Company.
??? Sorry die Optionen sind schon durch. Nur noch 60. Millionen warrants offen am 18. Juni 23 zu 0,26$ der Kurs wird sich erst dann bewegen wenn eine zählbare finanzielle news kommt. Wie hier schon öfters erwähnt wurde. Also Geduld und Vertrauen 😀
Bald müssten die Optionen verstrichen sein oder? War doch Ende März?
Dann sollte es ja endlich mal hochgehen
Dann sollte es ja endlich mal hochgehen
Durchsuchen
